BRIEF published on 08/28/2025 at 18:56, 6 months 26 days ago Bilan semestriel 2025 d'ABIONYX Pharma Chiffre D'affaires Trésorerie ABIONYX Pharma Soutien Financier Semestre 2025
BRIEF published on 08/28/2025 at 18:56, 6 months 26 days ago ABIONYX Pharma 2025 half-year review Treasury Financial Support Turnover ABIONYX Pharma Semester 2025
PRESS RELEASE published on 08/28/2025 at 18:51, 6 months 26 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma fait le point sur son activité et sa trésorerie du 1er semestre 2025, notamment un chiffre d'affaires de 2,1 M€ provenant de sa filiale IRIS Pharma. La trésorerie s'établit à 3,4 M€ Chiffre D'affaires Biotechnologie Trésorerie ABIONYX Pharma Thérapies Innovantes
PRESS RELEASE published on 08/28/2025 at 18:51, 6 months 26 days ago Inside Information / Other news releases ABIONYX Pharma provided an update on its activity and cash position for Q2 2025. Company's revenue, cash position, and government funding details revealed Revenue Cash Position Update Government Funding ABIONYX Pharma
BRIEF published on 08/27/2025 at 19:31, 6 months 27 days ago ABIONYX Pharma en pourparlers pour un partenariat stratégique dans le sepsis Partenariat Stratégique ABIONYX Pharma Sepsis CER-001 Thérapies Innovantes
BRIEF published on 08/27/2025 at 19:31, 6 months 27 days ago ABIONYX Pharma in talks for a strategic partnership in sepsis Strategic Partnership Innovative Therapies ABIONYX Pharma Sepsis CER-001
PRESS RELEASE published on 08/27/2025 at 19:26, 6 months 27 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce des discussions avec un acteur majeur du sepsis pour un partenariat stratégique. L'entreprise vise à accélérer le développement de CER-001 dans le sepsis Développement Partenariat Stratégique ABIONYX Pharma Sepsis CER-001
PRESS RELEASE published on 08/27/2025 at 19:26, 6 months 27 days ago Inside Information / Other news releases ABIONYX Pharma initiates discussions with a major sepsis player for strategic partnership, aiming to accelerate CER-001 development. Relevance of innovative technology validated Strategic Partnership Innovative Technology ABIONYX Pharma Sepsis CER-001
BRIEF published on 08/21/2025 at 23:20, 7 months 2 days ago ABIONYX : Structure du capital et droits de vote au 31 juillet 2025 Euronext Paris Droits De Vote Capital Social Actions ABIONYX
BRIEF published on 08/21/2025 at 23:20, 7 months 2 days ago ABIONYX: Capital structure and voting rights as of July 31, 2025 Euronext Paris Share Capital Voting Rights Actions ABIONYX
Published on 03/24/2026 at 13:30, 2 hours 14 minutes ago GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 2 hours 14 minutes ago Innodata Announces Date of Annual Shareholder Meeting
Published on 03/24/2026 at 12:35, 3 hours 9 minutes ago Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 12:33, 3 hours 11 minutes ago Mako Mining Completes Acquisition of Mt. Hamilton in Nevada
Published on 03/24/2026 at 12:30, 3 hours 14 minutes ago Orogen Reports Record 2025 Financial Performance and Positions for Continued Growth in 2026
Published on 03/24/2026 at 15:32, 11 minutes ago Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
Published on 03/24/2026 at 15:32, 11 minutes ago Résolutions de l’Assemblée générale mixte des actionnaires de Sartorius Stedim Biotech S.A.
Published on 03/24/2026 at 15:10, 34 minutes ago Michter's Distillery to Release 2026 Edition of Two Legacy Series Whiskeys: Shenk's Homestead & Bomberger's Declaration
Published on 03/24/2026 at 14:50, 54 minutes ago CoinShares Digital Securities Limited: EU CSDSL Individual - Additional Custodian (24.03)
Published on 03/24/2026 at 14:45, 59 minutes ago CoinShares Digital Securities Limited: EU CSDSL Index - Additional Custodian (24/03/2026)
Published on 03/24/2026 at 10:58, 4 hours 46 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of February 28, 2026
Published on 03/24/2026 at 10:58, 4 hours 46 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 28 février 2026
Published on 03/24/2026 at 07:45, 7 hours 59 minutes ago François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 7 hours 59 minutes ago La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 8 hours 14 minutes ago Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions
